RT Journal Article
T1 [Eleven years of economic evaluations of medical devices by the Spanish Network of Assessment Agencies. Methodological quality and cost-utility impact].
T2 Once años de evaluaciones económicas de productos sanitarios en la Red de Agencias de Evaluación. Calidad metodológica e impacto del coste-utilidad.
A1 Giménez, Emmanuel
A1 García-Pérez, Lidia
A1 Márquez, Sergio
A1 Gutiérrez, María Asun
A1 Bayón, Juan Carlos
A1 Espallargues, Mireia
K1 Cartera común
K1 Cost-effectiveness
K1 Coste-efectividad
K1 Economic evaluation
K1 Efficiency
K1 Eficiencia
K1 Evaluación de tecnologías sanitarias
K1 Evaluación económica
K1 Health technology assessment
K1 Medical devices
K1 National portfolio
K1 Productos sanitarios
AB To analyse the quality and impact of cost-utility evaluations of medical devices carried out by the Spanish Network of Assessment Agencies (RedETS). The cost-utility evaluations of medical devices were identified by searching the evaluation reports of the RedETS website database (2006-2016). Quality and its impact were evaluated with a RedETS quality checklist, comparing cost-utility results and inclusion in the portfolio of common services of the National Health System. The portfolio inclusion status was analysed considering whether the cost-effectiveness incremental ratio was or was not less than €25,000/quality adjusted life years. 25 cost-utility evaluations of medical devices were found (12 cost-utility, 10 cost-effectiveness and 3 both). Fifteen selected cost-utility studies with 19 cost-utility ratios met at least 18 of 25 verification criteria. Also, 12 of the 15 studies met 19 of the 25 criteria. On the impact, in 6 out of the 19 results, the product was included in the portfolio even though the ratio exceeded €25,000/quality adjusted life years. There are three cases undergoing a re-evaluation process, another case being reconsidered once the efficacy-safety of new devices has been reported and in two cases the portfolio states that protocols are required. Most of the cost-utility evaluations of medical devices published by RedETS fulfil most of the items on the checklist and, therefore, were thorough. These cost-utility evaluations of medical devices are consistent with the decision-making framework to efficiently manage the National Health System portfolio.
YR 2019
FD 2019-10-25
LK http://hdl.handle.net/10668/15577
UL http://hdl.handle.net/10668/15577
LA es
DS RISalud
RD Apr 19, 2025